Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Euriso-Top is a leading European producer of stable isotope-labeled compounds and deuterated solvents, serving the global life sciences and research communities. Founded in 1991 by a group of researchers from the French Atomic Energy Commission (CEA), the company specializes in high-purity reagents for NMR spectroscopy, mass spectrometry, and metabolic research. Their extensive product catalog includes labeled amino acids, carbohydrates, steroids, and gases essential for proteomics, metabolomics, and structural biology. As a subsidiary of Cambridge Isotope Laboratories (CIL) and part of the Otsuka Pharmaceutical group, Euriso-Top leverages significant manufacturing expertise to support drug discovery and clinical diagnostics. The company is headquartered in Saint-Aubin, France, within the Paris-Saclay innovation cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Euriso-Top.